The prescribing information is a living document updated when new safety information emerges
%20less%20than%2022%20who%20is%20taking%20Glucagon-Like%20Peptide-1%20(GLP-1)%20receptor%20agonists%2C%20such%20as%20semaglutide%20(GLP-1%20receptor%20agonist)%20or%20tirzepatide%20(GLP-1%20and%20glucose-dependent%20insulinotropic%20polypeptide%20receptor%20agonist)%2C%20for%20weight%20loss%3F)
[mp=title, book title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms, population supplementary concept word, anatomy supplementary concept word] 3018 7 5 or 6 3018 8 4 and 717 EBM Reviews - Cochrane Database of Systematic Reviews EBM Reviews - ACP Journal Club EBM Reviews - Database of Abstracts of Reviews of Effects EBM Reviews - Cochrane Clinical Answers EBM Reviews - Cochrane Central Register of Controlled Trials EBM Reviews - Cochrane Methodology Register EBM Reviews - Health Technology Assessment EBM Reviews - NHS Economic Evaluation Database 1 exp glucagon like peptide 1 receptor agonist/ 0 2 ((glucagon like peptide 1 receptor* or glucagon like peptide one receptor* or GLP-1RA*) adj3 (agonist* or antagonist* or medication* or drug* or agent* or analog*)).mp

As some people have already noticed, the drugs appear to cut the risk for some substance use disorders, including addictions to opioids, alcohol, stimulants and sedatives
Brightens skin and complexion
However, dietary effects pale compared to medication-induced receptor activation for weight management purposes